Chen Yong, Luo Sheng, Chu Haitao, Wei Peng
Stat Biopharm Res. 2013 May 1;5(2):142-155. doi: 10.1080/19466315.2013.791483.
Multivariate meta-analysis is useful in combining evidence from independent studies which involve several comparisons among groups based on a single outcome. For binary outcomes, the commonly used statistical models for multivariate meta-analysis are multivariate generalized linear mixed effects models which assume risks, after some transformation, follow a multivariate normal distribution with possible correlations. In this article, we consider an alternative model for multivariate meta-analysis where the risks are modeled by the multivariate beta distribution proposed by Sarmanov (1966). This model have several attractive features compared to the conventional multivariate generalized linear mixed effects models, including simplicity of likelihood function, no need to specify a link function, and has a closed-form expression of distribution functions for study-specific risk differences. We investigate the finite sample performance of this model by simulation studies and illustrate its use with an application to multivariate meta-analysis of adverse events of tricyclic antidepressants treatment in clinical trials.
多变量荟萃分析有助于整合来自独立研究的证据,这些研究基于单一结局在多组之间进行了多次比较。对于二元结局,多变量荟萃分析常用的统计模型是多变量广义线性混合效应模型,该模型假定经过某种变换后的风险服从具有可能相关性的多变量正态分布。在本文中,我们考虑一种用于多变量荟萃分析的替代模型,其中风险由Sarmanov(1966)提出的多变量贝塔分布建模。与传统的多变量广义线性混合效应模型相比,该模型具有几个吸引人的特点,包括似然函数简单、无需指定连接函数,并且对于研究特定的风险差异具有分布函数的封闭形式表达式。我们通过模拟研究来调查该模型的有限样本性能,并通过将其应用于临床试验中三环类抗抑郁药治疗不良事件的多变量荟萃分析来说明其用法。